Heart failure is common in people who have atrial fibrillation detected during screening, according to a presentation today at EHRA 2026,1 the annual congress of the European Heart Rhythm Association ...
Background The high prevalence of atrial fibrillation (AF) and its association with cardiovascular (CV) outcomes represent a ...
Pulse Biosciences, Inc. , developer of nPulsetm technology using proprietary nanosecond pulsed field ablation (nsPFAtm) energy, today announced plans to host an analyst event following the ...
The United Nations’ World Health Organization projects a shortfall of approximately 11 million health workers by 2030. As ...
Pulse Biosciences, Inc. , developer of nPulsetm technology using proprietary nanosecond pulsed field ablation (nsPFAtm) energy, today announced the strengthening of its executive leadership team with ...
Yet the evidence should not be overinterpreted, as conventional pacing maintains an important role, says Elena Arbelo.
Background Cancer survivors often face the risk of developing heart failure (HF) as a result of their previous cancer therapy ...
From its first use in 1998, to its status as a routine management strategy when medication is not an option, our understanding of catheter ablation for AF has grown immensely 4. Over the past 28 years ...
Former Norfolk Fire Brigade technician Trevor Palmer died for 15 minutes in a Norwich hospital and received a vision from God ...
A prespecified analysis of the NOAH-AFNET 6 trial investigated the impact of kidney function on cardiovascular outcome in ...
Miller School of Medicine could one day change the way people with atrial fibrillation are treated. Researchers at UM ...
Heart failure is common in people who have atrial fibrillation detected during screening, according to a presentation today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results